Patents by Inventor Ericka Pestana

Ericka Pestana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11058657
    Abstract: The invention relates to PUFA, vitamin E, vitamin D and the protein bound amino acids glycine, arginine and tryptophan as active ingredients for use in therapy of cancer patients, wherein an effective amount of said active ingredients is administered in the form of a nutritional composition comprising a) a lipid component providing 40-50 EN % based on the total energy of the nutritional composition, wherein 12-16 EN % based on the total energy of the nutritional composition is provided by PUFA, b) 4.0-8.0 mg/100 mL alpha-TE vitamin E, c) 5.0-12.0 ?g/100 mL vitamin D, d) 2.5-4.5 g/100 mL glycine, e) 0.5-1.5 g/100 mL arginine, and f) at least 0.02 g/100 mL tryptophan.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: July 13, 2021
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: Edmundo Brito-De-La Fuente, Ericka Pestana, Sarah Ashley-Maguire, Jose Maria Mainou-Sierra, Maria Fernanda Martinez-Bock, Stephanie Reichart
  • Publication number: 20200061013
    Abstract: The invention relates to PUFA, vitamin E, vitamin D and the protein bound amino acids glycine, arginine and tryptophan as active ingredients for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients, wherein an effective amount of said active ingredients is administered in the form of a nutritional composition comprising a) a lipid component providing 40-50 EN % based on the total energy of the nutritional composition, wherein 12-16 EN % based on the total energy of the nutritional composition is provided by PUFA, b) 4.0-8.0 mg/100 mL alpha-TE vitamin E, c) 5.0-12.0 ?g/100 mL vitamin D, d) 2.5-4.5 g/100 mL glycine, e) 0.5-1.5 g/100 mL arginine, and f) at least 0.02 g/100 mL tryptophan.
    Type: Application
    Filed: November 16, 2017
    Publication date: February 27, 2020
    Inventors: Edmundo BRITO-DE-LA-FUENTE, Ericka PESTANA, Stephanie REICHART, Maria Fernanda MARTINEZ-BOCK, Sarah ASHLEY, Jose Maria MAINOU-SIERRA
  • Publication number: 20190374495
    Abstract: The invention relates to PUFA, vitamin E, vitamin D and the protein bound amino acids glycine, arginine and tryptophan as active ingredients for use in therapy of cancer patients, wherein an effective amount of said active ingredients is administered in the form of a nutritional composition comprising a) a lipid component providing 40-50 EN % based on the total energy of the nutritional composition, wherein 12-16 EN % based on the total energy of the nutritional composition is provided by PUFA, b) 4.0-8.0 mg/100 mL alpha-TE vitamin E, c) 5.0-12.0 ?g/100 mL vitamin D, d) 2.5-4.5 g/100 mL glycine, e) 0.5-1.5 g/100 mL arginine, and f) at least 0.02 g/100 mL tryptophan.
    Type: Application
    Filed: November 16, 2017
    Publication date: December 12, 2019
    Inventors: Edmundo BRITO DE LA FUENTE, Ericka PESTANA, Sarah ASHLEY-MAGUIRE, José Maria MAINOU-SIERRA, Maria Fernanda MARTINEZ-BOCK, Stephanie REICHART
  • Publication number: 20190037903
    Abstract: A nutritional composition comprises a protein component, a lipid component and a carbohydrate component, minerals, vitamins and water, wherein the protein component comprises at least two different protein sources; wherein the first protein source is hydrolysed collagen; the lipid component provides at least 30 EN % of the total energy of the composition and the first source of protein represents 35-95 wt % based on the total weight of the protein component. The nutritional composition provides a homogeneous emulsion of high energy density (e.g. at least 3 kcal/mL) and high protein density (e.g. at least 14 g/100 mL).
    Type: Application
    Filed: February 3, 2017
    Publication date: February 7, 2019
    Applicant: Fresenius Kabi Deutschland GmbH
    Inventors: Edmundo BRITO DE LA FUENTE, Susanne KEIM, Ericka Pestana, Jose Maria Mainou-Sierra, Maria Femanda MARTINEZ-BOCK, Eileen WALLENFELS, Susanne Wiegand
  • Publication number: 20180343912
    Abstract: Enteral tube feed for patients in an intensive care unit comprising a lipid component, a carbohydrate component and at least 30 EN % of a protein component based on the total energy content of the enteral tube feed, wherein the protein component comprises a peptide fraction consisting of di-, tri- and oligopeptides with a molecular weight of at most 1 kD, wherein the peptide fraction provides at least 10 EN % of the total energy content of the enteral composition and wherein the carbohydrate component predominantly consists of carbohydrates having a GI of ?35 such as isomaltulose for use in treatment of ICU patients.
    Type: Application
    Filed: November 29, 2016
    Publication date: December 6, 2018
    Inventors: Edmundo BRITO DE LA FUENTE, Susanne KEIM, Ericka Pestana
  • Publication number: 20160044946
    Abstract: Dysphagia is a common health problem, the term describing a range of mechanical disorders that affect the safety, efficiency, or quality of eating and drinking. In dysphagia, every swallowing attempt bears the danger of choking and aspiration of liquids or food particles into the lung. Generally, when patients experience difficulties in swallowing, food thickeners are used to comply with clinically required levels of viscosity of liquid/semisolid products for use in nutrition for such patients. Herein, food thickening compositions as well as their use and applications are disclosed.
    Type: Application
    Filed: March 27, 2014
    Publication date: February 18, 2016
    Applicant: Fresenius Kabi Deutschland GMBH
    Inventors: Crispulo Gallegos-Montes, Edmundo Brito-De-La Fuente, Lida A. Quinchia-Bustamante, Ericka A. Pestana, Nadège Staudinger-Prévost, Getachew Assegehegn